| [1] |
Koelbl CO, Nedeljkovic ZS, Jacobs AK. Coronary chronic total occlusion(CTO)[J]. Rev Cardiovasc Med, 2018, 19(1): 33-39. |
| [2] |
Galassi AR, Brilakis ES, Boukhris M, et al. Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview[J]. Eur Heart J, 2016, 37(35): 2692-2700. doi:10.1093/eurheartj/ehv391URL |
| [3] |
Kandzari DE, Grantham JA, Karmpaliotis D, et al. Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study[J]. Coron Artery Dis, 2018, 29(8): 618-623. doi:10.1097/MCA.0000000000000668URL |
| [4] |
Wu EB, Tsuchikane E, Lo S, et al. Chronic total occlusion wiring: a state-of-the-art guide from the Asia Pacific Chronic Total Occlusion Club[J]. Heart Lung Circ, 2019, 28(10): 1490-1500. doi:10.1016/j.hlc.2019.04.004URL |
| [5] |
Tanabe M, Kodama K, Asada K, et al. Lesion characteristics and procedural outcomes of re-attempted percutaneous coronary interventions for chronic total occlusion[J]. Heart Vessels, 2018, 33(6): 573-582. doi:10.1007/s00380-017-1091-3URL |
| [6] |
Azzalini L, Carlino M, Brilakis ES, et al. Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: the concept of “vessel architecture”[J]. Catheter Cardiovasc Interv, 2018, 91(4): 725-734. doi:10.1002/ccd.27025URL |
| [7] |
Galassi AR, Sianos G, Werner GS, et al. Retrograde recanalization of chronic total occlusions in Europe: procedural, in-hospital, and long-term outcomes from the multicenter ERCTO registry[J]. J Am Coll Cardiol, 2015, 65(22): 2388-2400. doi:10.1016/j.jacc.2015.03.566URL |
| [8] |
Sakamoto A, Torii S, Jinnouchi H, et al. Histopathologic and physiologic effect of overlappingvssingle coronary stents: impact of stent evolution[J]. Expert Rev Med Devices, 2018, 15(9): 665-682. doi:10.1080/17434440.2018.1515012pmid:30132713 |
| [9] |
Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents[J]. Circ Cardiovasc Interv, 2019, 12(8): e007023. |
| [10] |
Carlino M, Figini F, Ruparelia N, et al. Predictors of restenosis following contemporary subintimal tracking and reentry technique: the importance of final TIMI flow grade[J]. Catheter Cardiovasc Interv, 2016, 87(5): 884-892. doi:10.1002/ccd.26103URL |
| [11] |
Azzalini L, Karatasakis A, Spratt JC, et al. Subadventitial stenting around occluded stents[J]. Catheter Cardiovasc Interv, 2018, 92(3): 466-476. doi:10.1002/ccd.27472URL |
| [12] |
Tadano Y, Kotani JI, Kashima Y, et al. Predictors of clinical outcomes after coronary implantation of bioresorbable polymer sirolimus-eluting ultimaster stents in all-comers[J]. Catheter Cardiovasc Interv, 2019, 94(1): 91-97. doi:10.1002/ccd.28076URL |
| [13] |
Yerasi C, Case BC, Forrestal BJ, et al. Drug-coated balloon forde novocoronary artery disease[J]. J Am Coll Cardiol, 2020, 75(9): 1061-1073. |
| [14] |
Rodriguez-Paz E, Heuser R. Staged CTO PCI: the investment that pays dividends[J]. Catheter Cardiovasc Interv, 2020, 96(5): 1036. doi:10.1002/ccd.29342URL |
| [15] |
Mashayekhi K, Büttner HJ. Chronic coronary occlusions : when and how should revascularization be performed?[J]. Herz, 2016, 41(7): 585-590. pmid:27484494 |
| [16] |
Xenogiannis I, Choi JW, Alaswad K, et al. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention[J]. Catheter Cardiovasc Interv, 2020, 96(5): 1029-1035. doi:10.1002/ccd.28614URL |